http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004531518-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
| filingDate | 2002-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004531518-A |
| titleOfInvention | Oxazolidinones as antibiotics containing sulfonimide groups |
| abstract | Formula (I) wherein HFT is, for example, an N-linked 5-membered fully unsaturated or partially unsaturated heterocycle or an N-linked 6-membered dihydroheteroaryl ring; Q is, for example, a Q1 or Q2, in this case Q1 and Q2, R 2 and R 3 are independently hydrogen or fluoro; T is for example, be selected from groups (TA1) or (TA2), At this time, in (TA1) and (TA2), for example, X 1m is O =, X 2m is R 2s- (E) ms -N-; E is -SO 2- , -CO-, etc. Wherein R 2s is, for example, hydrogen or (1-6C) alkyl; or a pharmaceutically acceptable salt of said compound, or an in vivo hydrolysable ester of said compound Is useful as a medicament. Methods for making these substances and pharmaceutical compositions containing these substances are disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014530232-A |
| priorityDate | 2001-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.